Structure Info
- Chemspace ID
- CSSS00015193672 (In-Stock Screening Compounds)
- CAS
- 1038915-60-4
- MFCD
- MFCD17779309
- IUPAC Name
- 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide
- Mol formula
- C19H20N4O
- Mol weight
- 320 Da
- Catalog Number(s)
- 0919AA, 22199, 42568, 133767, 42568-0.1G, 42568-0.25G, A1025, A298513, AA0038X2, AB51426, ACS-2299, ACS-787, AG0038ZU, AJ51426, AK04422, AOS0038ZU, AR0039OU, AS-35248, BD234046, CD31004753, CS-2789, CSC015193672, D388300, D572833, EN300-7364833, F227536, FP35532, HY-10619, J39270, JH39748, K12387, LAN-B48974, LN01331029, LQT-B49082, M10194, N481400, OR321439, S2741, SC-68044, SM00263, T3231, Z2724205341, scs-2299
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.47
- Heavy atoms count
- 24
- Rotatable bond count
- 3
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.263
- Polar surface area (Å)
- 73
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 2
- Zoom the structure
- CSSS00015193672
Items Overall 24 items from 4 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
Enamine Ltd | 5 days | Ukraine To: | 90 | 1 mg | 104 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 2 mg | 108 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 5 mg | 118 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 10 mg | 135 | |
Enamine Ltd | 5 days | Ukraine To: | 90 | 20 mg | 169 | |
MedChemExpress | 10 days | United States To: | 99 | 5 mg | 70 | |
MedChemExpress | 10 days | United States To: | 99 | 10 mg | 100 | |
MedChemExpress | 10 days | United States To: | 99 | 50 mg | 180 | |
MedChemExpress | 10 days | United States To: | 99 | 100 mg | 280 | |
MedChemExpress | 10 days | United States To: | 99 | 500 mg | 680 | |
MedChemExpress | 10 days | United States To: | 99 | 10mM/1mL | 77 | |
Description: Names: Niraparib; MK-4827; Product Description: Niraparib (MK-4827) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC 50 s of 3.8 and 2.1 nM, respectively. Niraparib leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity .; Target: Apoptosis;PARP; CAS: 1038915-60-4 | ||||||
MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 73 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 105 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 50 mg | 190 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 100 mg | 295 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 500 mg | 716 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10mM/1mL | 82 | |
Description: Names: Niraparib; MK-4827; Product Description: Niraparib (MK-4827) is a highly potent and orally bioavailable PARP1 and PARP2 inhibitor with IC50s of 3.8 and 2.1 nM, respectively. Niraparib leads to inhibition of repair of DNA damage, activates apoptosis and shows anti-tumor activity; Target: Apoptosis;PARP; CAS: 1038915-60-4 | ||||||
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 5 mg | 55 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 10 mg | 80 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 25 mg | 113 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 50 mg | 147 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 100 mg | 228 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 200 mg | 338 | |
Targetmol Chemicals Inc | 30 days | United States To: | 99 | 500 mg | 572 | |
Description: Niraparib (MK-4827) is a PARP inhibitor that selectively targets PARP1 and PARP2 (IC50=3.8/2.1 nM), exhibiting antitumor activity, inhibiting DNA damage repair, and inducing apoptosis.; CAS: 1038915-60-4 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire